Loss and preservation of beta-cell function: two treatment regimes targeting T or B lymphocytes
Curr Diab Rep
.
2010 Oct;10(5):323-5.
doi: 10.1007/s11892-010-0141-3.
Authors
Anette-G Ziegler
1
,
Markus Walter
Affiliation
1
Institut für Diabetesforschung, Helmholtz Zentrum München, German Research Center for Environmental Health & Forschergruppe Diabetes, Ingolstaedter Landstrasse 1, Neuherberg, Germany. anette-g.ziegler@helmholtz-muenchen.de
PMID:
20703833
DOI:
10.1007/s11892-010-0141-3
No abstract available
Publication types
Comment